Sector Expert: Jennifer Poland



Recent Quotes

"Preliminary results suggest DXD has a promising molecular imaging technology with potential to improve the management of AC patients who present with multiple lung lesions."

— Jennifer Poland, BioTuesdays Publishing Co. (12/7/16)
more >

"The FDA has given BCT clearance for a Phase 1/2a clinical trial of BriaVax."

— Jennifer Poland, BioTuesdays (11/4/15)
more >

"CANF's CF602 candidate showed a significant improvement in penile erection relative to placebo."

— Jennifer Poland, BioTuesdays (10/22/15)
more >



Due to permission requirements, not all quotes are shown.